CORDIS · 101001470 · H2020
PeptideKillers Peptide Killers of Bacteria
Coordinator: Masarykova univerzita (CZ)
Antibiotic-resistant bacteria cause more than 700 000 deaths per year, and the forecast is 10 million per year in 2050. Moreover, emerging strains of bacteria resistant to all available antibiotics may lead to a global post-antibiotic era. Because of this threat, the WHO and the UN are encouraging the research and development of new treatments. The aim of this proposal is to design new peptides that selectively target and disrupt the membranes of pathogens but not those of human cells. To obtain such peptides, we will develop an innovative coarse-grained model of membranes and an original gro…
About Horizon 2020 (2014–2020)
Horizon 2020 was the EU's flagship research and innovation programme for 2014–2020, with a budget of around €77 billion. It bundled FP7's strands with the EIT and the Competitiveness and Innovation Programme, introduced a stronger societal-challenge orientation, and pushed the funding logic toward closer-to-market innovation. New calls closed in 2020 but funded projects continued through 2024.
EU contribution: €2.3M awarded to the consortium. The project runs over approximately 5 years from 2022-01-01 to 2026-12-31.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu → Grant DOI ↗More from CZ
see all →- ESPOSA — Efficient Systems and Propulsion for Small Aircraft284859 · FP7 · €25.0M
- IMPULSE — Integrated Management and reliable oPerations for User-based Laser Scientific Excellence871161 · H2020 · €20.0M
- RICAIP — Research and Innovation Centre on Advanced Industrial Production857306 · H2020 · €15.0M
- FATRESCON — Concrete matrices for high-cycle-fatigue resistant, eco-efficient infrastructure101167045 · HORIZON · €10.0M
- CLOSER — Party Systems and Social Cleavages in the Post-Ottoman Space of the MENA Region101224232 · HORIZON · €9.8M
- 3Stops2Go — THREE STOP CODONS TO GET OVER TO FLOURISH101224040 · HORIZON · €9.8M
Other H2020 projects
see all →- EUROfusion — Implementation of activities described in the Roadmap to Fusion during Horizon 2020 through a Joint programme of the members of the EUROfusion consortium633053 · DE · €678.8M
- H2020 — COST at a turning point: A unique framework for pan-European ST cooperation as clear demonstration of European values681463 · BE · €178.2M
- HBP SGA3 — Human Brain Project Specific Grant Agreement 3945539 · BE · €150.0M
- COVID-19 VACCINES — PROPOSAL FOR FUNDING RESEARCH DEVELOPMENT AND MANUFACTURING OF VACCINE AGAINST COVID-19101018100 · NO · €100.0M
- UNITE4TB — ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS101007873 · NL · €92.5M
- ERA4TB — EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS853989 · ES · €89.8M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Horizon 2020 (2014–2020) programme, under the ERC-COG funding scheme.
- What is the EU contribution?
- The European Commission contributes €2.3M toward a total project budget of €2.3M.
- Which EU programme funds it?
- The project is funded under Horizon 2020 (2014–2020), call ERC-2020-COG.
- Who coordinates the project?
- The project is coordinated by Masarykova univerzita (CZ).
- What is the project timeline?
- The project runs from 2022-01-01 to 2026-12-31 — approximately 5 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 101001470.